Individualized Radiation Dose Escalation Based on the Decrease in Tumor FDG Uptake and Normal Tissue Constraints...

Area of Science:

• Oncology
• Radiation Oncology
• Medical Imaging

Background:

• Esophageal carcinoma treatment often involves chemoradiation.
• Assessing treatment response using positron emission tomography-computer tomography (PET-CT) is crucial.
• Identifying patients who can benefit from escalated radiation doses is an ongoing challenge.

Purpose of the Study:

• To evaluate if individualized radiation dose escalation improves survival in esophageal carcinoma patients.
• To assess if dose escalation, based on tumor and normal tissue constraints after chemoradiation, enhances outcomes.
• To determine the impact of dose escalation on metabolic response and survival rates.

Main Methods:

• 112 squamous esophageal carcinoma patients received concurrent chemoradiation.
• PET-CT scans were performed before and after radiation (50.4 Gy).
• 52 patients with non-complete metabolic response underwent individualized dose escalation; outcomes were compared to conventional treatment.

Main Results:

• Dose escalation increased complete metabolic response rates to 17.3% in non-responders.
• Two-year overall survival significantly improved from 20.5% to 42.8% (P=.001) with dose escalation.
• Two-year local control rates increased from 35.7% to 76.2% (P=.002).
• Survival benefit was most pronounced in patients with partial metabolic response (33.8% vs 78.4%; P=.000).

Conclusions:

• Individualized radiation dose escalation shows potential for improving survival in esophageal carcinoma.
• Increased complete metabolic response rates correlate with improved survival outcomes.
• Further research is necessary to validate these findings and pinpoint ideal candidates for dose escalation.